Targeting RIPK1,2,3 to combat inflammation

Detalles Bibliográficos
Autores principales: Bullock, Alex N., Degterev, Alexei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741430/
https://www.ncbi.nlm.nih.gov/pubmed/26472031
_version_ 1782413989381144576
author Bullock, Alex N.
Degterev, Alexei
author_facet Bullock, Alex N.
Degterev, Alexei
author_sort Bullock, Alex N.
collection PubMed
description
format Online
Article
Text
id pubmed-4741430
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-47414302016-03-15 Targeting RIPK1,2,3 to combat inflammation Bullock, Alex N. Degterev, Alexei Oncotarget Editorial Impact Journals LLC 2015-10-13 /pmc/articles/PMC4741430/ /pubmed/26472031 Text en Copyright: © 2015 Bullock and Degterev http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Editorial
Bullock, Alex N.
Degterev, Alexei
Targeting RIPK1,2,3 to combat inflammation
title Targeting RIPK1,2,3 to combat inflammation
title_full Targeting RIPK1,2,3 to combat inflammation
title_fullStr Targeting RIPK1,2,3 to combat inflammation
title_full_unstemmed Targeting RIPK1,2,3 to combat inflammation
title_short Targeting RIPK1,2,3 to combat inflammation
title_sort targeting ripk1,2,3 to combat inflammation
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4741430/
https://www.ncbi.nlm.nih.gov/pubmed/26472031
work_keys_str_mv AT bullockalexn targetingripk123tocombatinflammation
AT degterevalexei targetingripk123tocombatinflammation

Ejemplares similares